Vis enkel innførsel

dc.contributor.authorHikmat, Omar
dc.contributor.authorNaess, Karin
dc.contributor.authorEngvall, Martin
dc.contributor.authorKlingenberg, Claus
dc.contributor.authorRasmussen, Magnhild
dc.contributor.authorTallaksen, Chantal
dc.contributor.authorSamsonsen, Christian
dc.contributor.authorBrodtkorb, Eylert
dc.contributor.authorOstergaard, Elsebet
dc.contributor.authorde Coo, Rene
dc.contributor.authorPias-Peleteiro, Leticia
dc.contributor.authorIsohanni, Pirjo
dc.contributor.authorUusimaa, Johanna
dc.contributor.authorDarin, Niklas
dc.contributor.authorRahman, Shamima
dc.contributor.authorBindoff, Laurence
dc.date.accessioned2020-10-19T10:56:41Z
dc.date.available2020-10-19T10:56:41Z
dc.date.issued2020-09-18
dc.description.abstract<i>Objective</i> - To study the impact of gender, puberty, and pregnancy on the expression of POLG disease, one of the most common mitochondrial diseases known.<p> <p><i>Methods</i> - Clinical, laboratory, and genetic data were collected retrospectively from 155 patients with genetically confirmed POLG disease recruited from seven European countries. We used the available data to study the impact of gender, puberty, and pregnancy on disease onset and deterioration.<p> <p><i>Results</i> - We found that disease onset early in life was common in both sexes but there was also a second peak in females around the time of puberty. Further, pregnancy had a negative impact with 10 of 14 women (71%) experiencing disease onset or deterioration during pregnancy.<p> <p><i>Interpretation</i> - Gender clearly influences the expression of POLG disease. While onset very early in life was common in both males and females, puberty in females appeared associated both with disease onset and increased disease activity. Further, both disease onset and deterioration, including seizure aggravation and status epilepticus, appeared to be associated with pregnancy. Thus, whereas disease activity appears maximal early in life with no subsequent peaks in males, both menarche and pregnancy appear associated with disease onset or worsening in females. This suggests that hormonal changes may be a modulating factor.en_US
dc.identifier.citationHikmat, Naess, Engvall, Klingenberg, Rasmussen, Tallaksen, Samsonsen, Brodtkorb, Ostergaard, de Coo, Pias-Peleteiro, Isohanni, Uusimaa, Darin, Rahman, Bindoff. The impact of gender, puberty, and pregnancy in patients with POLG disease. Annals of clinical and translational neurology. 2020:1-7en_US
dc.identifier.cristinIDFRIDAID 1832983
dc.identifier.doi10.1002/acn3.51199
dc.identifier.issn2328-9503
dc.identifier.urihttps://hdl.handle.net/10037/19623
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.journalAnnals of clinical and translational neurology
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2020 The Author(s)en_US
dc.subjectVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710en_US
dc.subjectVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710en_US
dc.titleThe impact of gender, puberty, and pregnancy in patients with POLG diseaseen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel